Neogen (NEOG) plans investor tours to showcase Petrifilm validation progress

Q: Why is Neogen sharing Petrifilm qualification updates with investors?

Neogen is providing a Regulation FD update as it hosts investor tours of its Petrifilm manufacturing facility. The company intends to share that multiple operational qualifications are complete and performance qualifications are in progress for certain Petrifilm single kit units, describing these steps as part of its overall validation efforts.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Neogen Corporation filed a current report describing upcoming investor outreach and progress on product validation. The company plans to host two investor tours of its Petrifilm manufacturing facility in Lansing, Michigan on April 20, 2026 and April 21, 2026.

Neogen states it has successfully completed multiple operational qualifications for certain Petrifilm single kit units and is now proceeding with multiple performance qualifications for these SKUs as part of its broader validation efforts. This technical and validation update will be shared with investors during the facility tours.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Terms

Regulation FD Disclosure, operational qualifications, performance qualifications, validation efforts

4 terms

Regulation FD Disclosure regulatory

"Item 7.01 Regulation FD Disclosure."

operational qualifications technical

"has now successfully completed multiple operational qualifications for certain Petrifilm"

performance qualifications technical

"proceeding forward on multiple performance qualifications for these SKUs"

validation efforts technical

"as part of its overall validation efforts."

Understanding 8-K Material Events →

04/20/2026 - 06:59 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported): April 20, 2026

    

Neogen Corporation

(Exact name of Registrant as Specified in Its Charter)


Michigan	0-17988	38-2367843
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

620 Lesher Place
Lansing, Michigan		48912
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: (517) 372-9200

    

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.16 par value per share	NEOG	Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Neogen is planning to host two investor tours of its Petrifilm manufacturing facility in Lansing, Michigan on April 20, 2026 and April 21, 2026. The company is disclosing that it has now successfully completed multiple operational qualifications for certain Petrifilm single kit units (SKUs) and is proceeding forward on multiple performance qualifications for these SKUs as part of its overall validation efforts. This information will be shared with investors during the tours.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits




104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			NEOGEN CORPORATION

Date:	April 20, 2026	By:	/s/ Jennifer Evans Stacey
			Name: Jennifer Evans Stacey Title: Senior Vice President & Chief Legal and Compliance Officer and Corporate Secretary

Source: View Original Filing on SEC EDGAR

FAQ

What did Neogen (NEOG) announce in this Form 8-K filing?

Neogen reported upcoming investor tours and progress on Petrifilm validation work. The company has completed multiple operational qualifications for certain Petrifilm single kit units and is moving into performance qualifications, with these updates to be discussed during investor tours at its Lansing, Michigan facility.

When and where are Neogen’s Petrifilm investor facility tours?

Neogen plans two investor tours at its Petrifilm manufacturing facility in Lansing, Michigan on April 20, 2026 and April 21, 2026. During these visits, the company will share information on operational and performance qualifications for specific Petrifilm single kit units as part of ongoing validation work.

What validation progress did Neogen report for its Petrifilm SKUs?

Neogen reported successfully completing multiple operational qualifications for certain Petrifilm single kit units. It is now proceeding with multiple performance qualifications for those SKUs, which are described as part of the company’s overall validation efforts that will be highlighted during the planned investor facility tours.

Which Neogen products are discussed in this 8-K disclosure?

The disclosure focuses on Petrifilm single kit units, identified as specific SKUs within Neogen’s product line. The company highlights that multiple operational qualifications are complete and that performance qualifications for these Petrifilm SKUs are underway as part of broader validation activities to be presented to investors.

Filing Exhibits & Attachments

1 document